Related references
Note: Only part of the references are listed.Operative and Therapeutic Advancements in Breast Cancer Metastases to the Brain
Rahul Jandial et al.
CLINICAL BREAST CANCER (2018)
Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma
Jason Chesney et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
PTEN-L promotes type I interferon responses and antiviral immunity
Yuanyuan Cao et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection-Implications for Oncolytic Viral Therapy
Chelsea Bolyard et al.
CLINICAL CANCER RESEARCH (2017)
Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy
E. Ilett et al.
GENE THERAPY (2017)
Safety, tolerability and antitumour activity of LY2780301 (p70S6K/AKT inhibitor) in combination with gemcitabine in molecularly selected patients with advanced or metastatic cancer: a phase IB dose escalation study
Eric Angevin et al.
EUROPEAN JOURNAL OF CANCER (2017)
Phase II trial of the PI3 kinase inhibitor buparlisib (BKM-120) with or without enzalutamide in men with metastatic castration resistant prostate cancer
Andrew J. Armstrong et al.
EUROPEAN JOURNAL OF CANCER (2017)
Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma
Suzanne George et al.
IMMUNITY (2017)
The P2X7 Receptor in Infection and Inflammation
Francesco Di Virgilio et al.
IMMUNITY (2017)
Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells
Hannah H. Chen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Oncolytic VSV Primes Differential Responses to Immuno-oncology Therapy
Nicholas M. Durham et al.
MOLECULAR THERAPY (2017)
Local Delivery of OncoVEXmGM-CSF Generates Systemic AntitumorImmuneResponses Enhanced by Cytotoxic T-Lymphocyte-Associated Protein Blockade
Achim K. Moesta et al.
CLINICAL CANCER RESEARCH (2017)
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
Antoni Ribas et al.
CELL (2017)
IDO, PTEN-expressing Tregs and control of antigen-presentation in the murine tumor microenvironment
David H. Munn et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Oncolytic Adenovirus and Tumor-Targeting Immune Modulatory Therapy Improve Autologous Cancer Vaccination
Hong Jiang et al.
CANCER RESEARCH (2017)
Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group
P-E Heudel et al.
BRITISH JOURNAL OF CANCER (2017)
Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
Weiyi Peng et al.
CANCER DISCOVERY (2016)
Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma
Robert H. I. Andtbacka et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma
Igor Puzanov et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Combined-Modality Therapy With Radiation and Chemotherapy for Elderly Patients With Glioblastoma in the Temozolomide Era A National Cancer Database Analysis
Chad G. Rusthoven et al.
JAMA NEUROLOGY (2016)
PTEN inhibits macrophage polarization from M1 to M2 through CCL2 and VEGF-A reduction and NHERF-1 synergism
Ning Li et al.
CANCER BIOLOGY & THERAPY (2015)
The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor Microenvironment
W. Hans Meisen et al.
CLINICAL CANCER RESEARCH (2015)
PTEN Is a Negative Regulator of NK Cell Cytolytic Function
Edward L. Briercheck et al.
JOURNAL OF IMMUNOLOGY (2015)
Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
Lin Zhang et al.
NATURE (2015)
PTEN regulates natural killer cell trafficking in vivo
Jeffrey W. Leong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Changes in BAI1 and Nestin Expression Are Prognostic Indicators for Survival and Metastases in Breast Cancer and Provide Opportunities for Dual Targeted Therapies
Walter Hans Meisen et al.
MOLECULAR CANCER THERAPEUTICS (2015)
The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis
Paula de Robles et al.
NEURO-ONCOLOGY (2015)
Management of solitary and multiple brain metastases from breast cancer
Addison Willett et al.
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY (2015)
PTENα, a PTEN Isoform Translated through Alternative Initiation, Regulates Mitochondrial Function and Energy Metabolism
Hui Liang et al.
CELL METABOLISM (2014)
Metastatic progression of breast cancer: insights from 50 years of autopsies
Margaret C. Cummings et al.
JOURNAL OF PATHOLOGY (2014)
Faster Replication and Higher Expression Levels of Viral Glycoproteins Give the Vesicular Stomatitis Virus/Measles Virus Hybrid VSV-FH a Growth Advantage over Measles Virus
Camilo Ayala-Breton et al.
JOURNAL OF VIROLOGY (2014)
Blockade of mTOR Signaling via Rapamycin Combined with Immunotherapy Augments Antiglioma Cytotoxic and Memory T-Cell Functions
Yohei Mineharu et al.
MOLECULAR CANCER THERAPEUTICS (2014)
CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy
Christine E. Engeland et al.
MOLECULAR THERAPY (2014)
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
Dmitriy Zamarin et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Functions and regulation of the PTEN gene in colorectal cancer
Francesca Molinari et al.
FRONTIERS IN ONCOLOGY (2014)
PTEN-mediated akt/β-Catenin/foxo1 signaling regulates innate immune responses in mouse liver ischemia/reperfusion injury
Naoko Kamo et al.
HEPATOLOGY (2013)
PTEN Loss Increases PD-L1 Protein Expression and Affects the Correlation between PD-L1 Expression and Clinical Parameters in Colorectal Cancer
Minmin Song et al.
PLOS ONE (2013)
A Secreted PTEN Phosphatase That Enters Cells to Alter Signaling and Survival
Benjamin D. Hopkins et al.
SCIENCE (2013)
Oncolytic HSV-1 Virotherapy: Clinical Experience and Opportunities for Progress
Balveen Kaur et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
Inflammasomes in carcinogenesis and anticancer immune responses
Laurence Zitvogel et al.
NATURE IMMUNOLOGY (2012)
Epidemiology of Brain Metastases
Lakshmi Nayak et al.
CURRENT ONCOLOGY REPORTS (2012)
Preclinical Evaluation of Oncolytic Δγ134.5 Herpes Simplex Virus Expressing Interleukin-12 for Therapy of Breast Cancer Brain Metastases
James J. Cody et al.
INTERNATIONAL JOURNAL OF BREAST CANCER (2012)
Chondroitinase ABC I-Mediated Enhancement of Oncolytic Virus Spread and Antitumor Efficacy
Nina Dmitrieva et al.
CLINICAL CANCER RESEARCH (2011)
Herpes Simplex Virus Requires VP11/12 To Activate Src Family Kinase-Phosphoinositide 3-Kinase-Akt Signaling
Melany J. Wagner et al.
JOURNAL OF VIROLOGY (2011)
Enhanced Antitumor Efficacy of Vasculostatin (Vstat120) Expressing Oncolytic HSV-1
Jayson Hardcastle et al.
MOLECULAR THERAPY (2010)
Buy One Get One Free: Armed Viruses for the Treatment of Cancer Cells and their Microenvironment
Balveen Kaur et al.
CURRENT GENE THERAPY (2009)
Gamma interferon-mediated superinduction of B7-H1 in PTEN-deficient glioblastoma: a paradoxical mechanism of immune evasion
Seunggu J. Han et al.
NEUROREPORT (2009)
Combination of a fusogenic glycoprotein, prodrug activation, and oncolytic herpes simplex virus for enhanced local tumor control
Guy R. Simpson et al.
CANCER RESEARCH (2006)
Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models
K Terada et al.
GENE THERAPY (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
An oncolytic adenovirus vector combining enhanced cell-to-cell spreading, mediated by the ADP cytolytic protein, with selective replication in cancer cells with deregulated Wnt signaling
K Toth et al.
CANCER RESEARCH (2004)
Share Paper
